Rosiglitazone reduces fatty acid translocase and increases AMPK in skeletal muscle in aged rats： a possible mechanism to prevent high-fat-induced insulin resistance

Background As an agonist of peroxisome proliferator-activated receptor-gamma （PPARy）, rosiglitazone can prevent acute fatty acid-induced insulin resistance in rats, however, the precise mechanisms by which rosiglitazone alleviates insulin resistance induced by high-fat diet need to be further invest...

Ausführliche Beschreibung